Anti-obesity medication or weight loss medications are pharmacological agents that reduce or control weight. These medications alter one of the fundamental processes of the human body, weight regulation, by altering either appetite, or absorption of calories.
We aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Case numbers are resurging in parts of the world where the COVID-19 pandemic was waning, falling in places that saw huge surges recently, and just beginning to rise in previously little-impacted parts of the globe.
Studying and analyzing the impact of Coronavirus COVID-19 on the Anti-Obesity Prescription Drugs industry, the report provide in-depth analysis and professtional advices on how to face the post COIVD-19 period.
Market Segment by Product Type
Orlistat
Phentermine and Topiramate
Bupropion and Naltrexone
Lorcaserin
Liraglutide
Market Segment by Product Application
Pediatric
Adult
Finally, the report provides detailed profile and data information analysis of leading company.
F Hoffmann La Roche Ltd
Orexigen Therapeutics
Novo Nordisk A/s
Arena Pharmaceuticals
Glaxosmithkline
Vivus
Boehringer Ingelheim
Alizyme
Insights and Tools:
Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation.
Product values and regional markets are estimated by market analyst, data analyst and people from related industry, based on companys' revenue and applications market respectively.
The data sources include but not limited to reports of companys,international organizations and governments, MMI market surveys,and related industry news.
Analyses of global market trends, with historical data, estimates for 2022 and projections of compound annual growth rates (CAGRs) through 2027
The market research includes historical and forecast data from like demand, application details, price trends, and company shares by geography, especially focuses on the key regions like United States, European Union, China, and other regions.
In addition, the report provides insight into main drivers,challenges,opportunities and risk of the market and strategies of suppliers. Key players are profiled as well with their market shares in the global market discussed.
Research Objectives
1.To study and analyze the global Anti-Obesity Prescription Drugs consumption (value) by key regions/countries, product type and application, history data from 2017 to 2021, and forecast to 2027.
2.To understand the structure of Anti-Obesity Prescription Drugs market by identifying its various subsegments.
3.Focuses on the key global Anti-Obesity Prescription Drugs manufacturers, to define, describe and analyze the value, market share, market competition landscape, Porter's five forces analysis, SWOT analysis and development plans in next few years.
4.To analyze the Anti-Obesity Prescription Drugs with respect to individual growth trends, future prospects, and their contribution to the total market.
5.To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
6.To project the consumption of Anti-Obesity Prescription Drugs submarkets, with respect to key regions (along with their respective key countries).
7.To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
8.To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
Global Anti-Obesity Prescription Drugs Market Research Report 2022, Forecast to 2027
1 Market Study Overview
1.1 Study Objectives
1.2 Anti-Obesity Prescription Drugs Introduce
1.3 Combined with the Analysis of Macroeconomic Indicators
1.4 Brief Description of Research methods
1.5 Market Breakdown and Data Triangulation
2 Global Trend Summary
2.1 Anti-Obesity Prescription Drugs Segment by Type
2.1.1 Orlistat
2.1.2 Phentermine and Topiramate
2.1.3 Bupropion and Naltrexone
2.1.4 Lorcaserin
2.1.5 Liraglutide
2.2 Market Analysis by Application
2.2.1 Pediatric
2.2.2 Adult
2.3 Global Anti-Obesity Prescription Drugs Market Comparison by Regions (2017-2027)
2.3.1 Global Anti-Obesity Prescription Drugs Market Size (2017-2027)
2.3.2 North America Anti-Obesity Prescription Drugs Status and Prospect (2017-2027)
2.3.3 Europe Anti-Obesity Prescription Drugs Status and Prospect (2017-2027)
2.3.4 China Anti-Obesity Prescription Drugs Status and Prospect (2017-2027)
2.3.5 Japan Anti-Obesity Prescription Drugs Status and Prospect (2017-2027)
2.3.6 Southeast Asia Anti-Obesity Prescription Drugs Status and Prospect (2017-2027)
2.4 Basic Product Information
2.4.1 Basic Product Information & Technology Development History
2.4.2 Product Manufacturing Process
2.4.3 Interview with Major Market Participants
2.4.4 High-end Market Analysis and Forecast
2.5 Coronavirus Disease 2019 (Covid-19): Anti-Obesity Prescription Drugs Industry Impact
2.5.1 Anti-Obesity Prescription Drugs Business Impact Assessment - Covid-19
2.5.2 Market Trends and Anti-Obesity Prescription Drugs Potential Opportunities in the COVID-19 Landscape
2.5.3 Measures / Proposal against Covid-19
3 Competition by Manufacturer
3.1 Global Anti-Obesity Prescription Drugs Sales and Market Share by Manufacturer (2017-2022)
3.2 Global Anti-Obesity Prescription Drugs Revenue and Market Share by Manufacturer (2017-2022)
3.3 Global Anti-Obesity Prescription Drugs Industry Concentration Ratio (CR5 and HHI)
3.4 Top 5 Anti-Obesity Prescription Drugs Manufacturer Market Share
3.5 Top 10 Anti-Obesity Prescription Drugs Manufacturer Market Share
3.6 Date of Key Manufacturers Enter into Anti-Obesity Prescription Drugs Market
3.7 Key Manufacturers Anti-Obesity Prescription Drugs Key Manufacturers
3.8 Mergers & Acquisitions Planning
4 Analysis of Anti-Obesity Prescription Drugs Industry Key Manufacturers
4.1 F Hoffmann La Roche Ltd
4.1.1 Compan Detail
4.1.2 F Hoffmann La Roche Ltd Anti-Obesity Prescription Drugs Product Introduction, Application and Specification
4.1.3 F Hoffmann La Roche Ltd 132 Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.1.4 Main Business Overview
4.1.5 F Hoffmann La Roche Ltd News
4.2 Orexigen Therapeutics
4.2.1 Compan Detail
4.2.2 Orexigen Therapeutics Anti-Obesity Prescription Drugs Product Introduction, Application and Specification
4.2.3 Orexigen Therapeutics Anti-Obesity Prescription Drugs Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.2.4 Main Business Overview
4.2.5 F Hoffmann La Roche Ltd News
4.3 Novo Nordisk A/s
4.3.1 Compan Detail
4.3.2 Novo Nordisk A/s Anti-Obesity Prescription Drugs Product Introduction, Application and Specification
4.3.3 Novo Nordisk A/s Anti-Obesity Prescription Drugs Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.3.4 Main Business Overview
4.3.5 Novo Nordisk A/s News
4.4 Arena Pharmaceuticals
4.4.1 Compan Detail
4.4.2 Arena Pharmaceuticals Anti-Obesity Prescription Drugs Product Introduction, Application and Specification
4.4.3 Arena Pharmaceuticals Anti-Obesity Prescription Drugs Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.4.4 Main Business Overview
4.4.5 Arena Pharmaceuticals News
4.5 Glaxosmithkline
4.5.1 Compan Detail
4.5.2 Arena Pharmaceuticals Anti-Obesity Prescription Drugs Product Introduction, Application and Specification
4.5.3 Glaxosmithkline Anti-Obesity Prescription Drugs Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.5.4 Main Business Overview
4.5.5 Glaxosmithkline News
4.6 Vivus
4.6.1 Compan Detail
4.6.2 Vivus Anti-Obesity Prescription Drugs Product Introduction, Application and Specification
4.6.3 Vivus Anti-Obesity Prescription Drugs Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.6.4 Main Business Overview
4.6.5 Vivus News
4.7 Boehringer Ingelheim
4.7.1 Compan Detail
4.7.2 Boehringer Ingelheim Anti-Obesity Prescription Drugs Product Introduction, Application and Specification
4.7.3 Boehringer Ingelheim Anti-Obesity Prescription Drugs Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.7.4 Main Business Overview
4.7.4 Main Business Overview
4.8 Alizyme
4.8.1 Compan Detail
4.8.2 Alizyme Anti-Obesity Prescription Drugs Product Introduction, Application and Specification
4.8.3 Alizyme Anti-Obesity Prescription Drugs Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.8.4 Main Business Overview
4.8.5 Alizyme News
5 Global Anti-Obesity Prescription Drugs Market Segment by Big Type
5.1 Global Anti-Obesity Prescription Drugs Revenue, Sales and Market Share by Big Type (2017-2022)
5.1.1 Global Anti-Obesity Prescription Drugs Sales and Market Share by Big Type (2017-2022)
5.1.2 Global Anti-Obesity Prescription Drugs Revenue and Market Share by Big Type (2017-2022)
5.2 Orlistat Sales Growth Rate and Price
5.2.1 Global Orlistat Sales Growth Rate (2017-2022)
5.2.2 Global Orlistat Price (2017-2022)
5.3 Phentermine and Topiramate Sales Growth Rate and Price
5.3.1 Global Phentermine and Topiramate Sales Growth Rate (2017-2022)
5.3.2 Global Phentermine and Topiramate Price (2017-2022)
5.4 Bupropion and Naltrexone Sales Growth Rate and Price
5.4.1 Global Bupropion and Naltrexone Sales Growth Rate (2017-2022)
5.4.2 Global Bupropion and Naltrexone Price (2017-2022)
5.5 Lorcaserin Sales Growth Rate and Price
5.5.1 Global Lorcaserin Sales Growth Rate (2017-2022)
5.5.2 Global Lorcaserin Price (2017-2022)
5.6 Liraglutide Sales Growth Rate and Price
5.6.1 Global Liraglutide Sales Growth Rate (2017-2022)
5.6.2 Global Liraglutide Price (2017-2022)
6 Global Anti-Obesity Prescription Drugs Market Segment by Big Application
6.1 Global Anti-Obesity Prescription Drugs Sales Market Share by Big Application (2017-2022)
6.2 Pediatric Sales Growth Rate (2017-2022)
6.3 Adult Sales Growth Rate (2017-2022)
7 Global Anti-Obesity Prescription Drugs Forecast
7.1 Global Anti-Obesity Prescription Drugs Revenue, Sales and Growth Rate (2022-2027)
7.2 Anti-Obesity Prescription Drugs Market Forecast by Regions (2022-2027)
7.2.1 North America Anti-Obesity Prescription Drugs Market Forecast (2022-2027)
7.2.2 Europe Anti-Obesity Prescription Drugs Market Forecast (2022-2027)
7.2.3 China Anti-Obesity Prescription Drugs Market Forecast (2022-2027)
7.2.4 Japan Anti-Obesity Prescription Drugs Market Forecast (2022-2027)
7.2.5 Southeast Asia Anti-Obesity Prescription Drugs Market Forecast (2022-2027)
7.2.6 Other Regions Anti-Obesity Prescription Drugs Market Forecast (2022-2027)
7.3 Anti-Obesity Prescription Drugs Market Forecast by Type (2022-2027)
7.3.1 Global Anti-Obesity Prescription Drugs Sales Forecast by Type (2022-2027)
7.3.2 Global Anti-Obesity Prescription Drugs Market Share Forecast by Type (2022-2027)
7.4 Anti-Obesity Prescription Drugs Market Forecast by Application (2022-2027)
7.4.1 Global Anti-Obesity Prescription Drugs Sales Forecast by Application (2022-2027)
7.4.2 Global Anti-Obesity Prescription Drugs Market Share Forecast by Application (2022-2027)
8 Market Analysis
8.1.1 Market Overview
8.1.2 Market Opportunities
8.1.3 Market Risk
8.1.4 Market Driving Force
8.1.5 Porter's Five Forces Analysis
8.1.6 SWOT Analysis
9 Anti-Obesity Prescription Drugs Related Market Analysis
9.1 Upstream Analysis
9.1.1 Macro Analysis of Upstream Markets
9.1.2 Key Players in Upstream Markets
9.1.3 Upstream Market Trend Analysis
9.1.4 Anti-Obesity Prescription Drugs Manufacturing Cost Analysis
9.2 Downstream Market Analysis
9.2.1 Macro Analysis of Down Markets
9.2.2 Key Players in Down Markets
9.2.3 Downstream Market Trend Analysis
9.2.4 Sales Channel, Distributors, Traders and Dealers
10 Research Findings and Conclusion
List of Tables and Figures
Figure Product Picture Anti-Obesity Prescription Drugs
Figure Market Concentration Ratio and Market Maturity Analysis of Anti-Obesity Prescription Drugs
Figure Bottom-up and Top-down Approaches for This Report
Figure Part of Our External Database
Figure Part of Our External Database
Figure Key Executives Interviewed
Table Global Anti-Obesity Prescription Drugs Market Size by Big Type
Figure Global Market Share of Anti-Obesity Prescription Drugs by Big Type in 2021
Figure Orlistat Picture (2017-2022)
Figure Phentermine and Topiramate Picture (2017-2022)
Figure Bupropion and Naltrexone Picture (2017-2022)
Figure Lorcaserin Picture (2017-2022)
Global Anti-Obesity Prescription Drugs Market Size by Big Application
Table Global Anti-Obesity Prescription Drugs Market Size by Application
Figure Global Anti-Obesity Prescription Drugs Market Share by Big Application in 2021
Figure Pediatric Picture
Figure Adult Picture
Table Global Anti-Obesity Prescription Drugs Comparison by Regions (M USD) (2017-2027)
Figure Global Anti-Obesity Prescription Drugs Market Size (Million US$) (2017-2027)
Figure North America Anti-Obesity Prescription Drugs Revenue (Million US$) Growth Rate (2017-2027)
Figure Europe Anti-Obesity Prescription Drugs Revenue (Million US$) Growth Rate (2017-2027)
Figure China Anti-Obesity Prescription Drugs Revenue (Million US$) Growth Rate (2017-2027)
Figure Japan Anti-Obesity Prescription Drugs Revenue (Million US$) Growth Rate (2017-2027)
Figure Southeast Asia Anti-Obesity Prescription Drugs Revenue (Million US$) Growth Rate (2017-2027)
Table Business Impact Assessment - Covid-19
Table Market Trends and Anti-Obesity Prescription Drugs Potential Opportunities in the COVID-19 Landscape
Table Measures / Proposal against Covid-19
Table Global Anti-Obesity Prescription Drugs Sales by Manufacturer (2017-2022)
Figure Global Anti-Obesity Prescription Drugs Sales Market Share by Manufacturer in 2021
Table Global Anti-Obesity Prescription Drugs Revenue by Manufacturer (2017-2022)
Figure Global Anti-Obesity Prescription Drugs Revenue Market Share by Manufacturer in 2021
Table Global Anti-Obesity Prescription Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Figure Top 5 Anti-Obesity Prescription Drugs Manufacturer (Revenue) Market Share in 2021
Figure Top 10 Anti-Obesity Prescription Drugs Manufacturer (Revenue) Market Share in 2021
Table Date of Key Manufacturers Enter into Anti-Obesity Prescription Drugs Market
Table Key Manufacturers Anti-Obesity Prescription Drugs Product Type
Table Mergers & Acquisitions Planning
Table F Hoffmann La Roche Ltd Company Profile
Table Anti-Obesity Prescription Drugs Product Introduction, Application and Specification of F Hoffmann La Roche Ltd
Table Anti-Obesity Prescription Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company One 2017-2022
Table Company One Main Business
Table Company One Recent Development
Table Orexigen Therapeutics Company Profile
Table Anti-Obesity Prescription Drugs Product Introduction, Application and Specification of Orexigen Therapeutics
Table Anti-Obesity Prescription Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Orexigen Therapeutics Recent Development
Table Novo Nordisk A/s Company Profile
Table Anti-Obesity Prescription Drugs Product Introduction, Application and Specification of Novo Nordisk A/s
Table Anti-Obesity Prescription Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Novo Nordisk A/s Main Business
Table Novo Nordisk A/s Recent Development
Table Arena Pharmaceuticals Company Profile
Table Anti-Obesity Prescription Drugs Product Introduction, Application and Specification of Arena Pharmaceuticals
Table Anti-Obesity Prescription Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Arena Pharmaceuticals Main Business
Table Arena Pharmaceuticals Recent Development
Table Arena Pharmaceuticals Main Business
Table Arena Pharmaceuticals Recent Development
Table Glaxosmithkline Company Profile
Table Anti-Obesity Prescription Drugs Product Introduction, Application and Specification of Glaxosmithkline
Table Anti-Obesity Prescription Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Glaxosmithkline Main Business
Table Glaxosmithkline Recent Development
Table Vivus Company Profile
Table Anti-Obesity Prescription Drugs Product Introduction, Application and Specification of Vivus
Table Anti-Obesity Prescription Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Vivus Main Business
Table Vivus Recent Development
Table Boehringer Ingelheim Company Profile
Table Anti-Obesity Prescription Drugs Product Introduction, Application and Specification of Boehringer Ingelheim
Table Anti-Obesity Prescription Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Boehringer Ingelheim Main Business
Table Boehringer Ingelheim Recent Development
Table Alizyme Company Profile
Table Anti-Obesity Prescription Drugs Product Introduction, Application and Specification of Alizyme
Table Anti-Obesity Prescription Drugs Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Alizyme Main Business
Table Alizyme Recent Development
Figure Global Anti-Obesity Prescription Drugs Sales and Growth Rate (2017-2022)
Figure Global Anti-Obesity Prescription Drugs Revenue and Growth Rate (2017-2022)
Table Global Anti-Obesity Prescription Drugs Sales by Regions (2017-2022)
Figure Global Anti-Obesity Prescription Drugs Sales Market Share by Regions in 2021
Table Global Anti-Obesity Prescription Drugs Revenue by Regions (2017-2022)
Figure Global Anti-Obesity Prescription Drugs Revenue Market Share by Regions in 2021
Figure North America Anti-Obesity Prescription Drugs Sales and Growth Rate (2017-2022)
Figure Europe Anti-Obesity Prescription Drugs Sales and Growth Rate (2017-2022)
Figure China Anti-Obesity Prescription Drugs Sales and Growth Rate (2017-2022)
Figure Japan Anti-Obesity Prescription Drugs Sales and Growth Rate (2017-2022)
Figure Southeast Asia Anti-Obesity Prescription Drugs Sales and Growth Rate (2017-2022)
Figure Other Regions Anti-Obesity Prescription Drugs Sales and Growth Rate (2017-2022)
Table Global Anti-Obesity Prescription Drugs Sales by Big Type (2017-2022)
Table Global Anti-Obesity Prescription Drugs Sales Market Share by Big Type (2017-2022)
Figure Global Anti-Obesity Prescription Drugs Sales Market Share by Big Type in 2019
Table Global Anti-Obesity Prescription Drugs Revenue by Big Type (2017-2022)
Table Global Anti-Obesity Prescription Drugs Revenue Market Share by Big Type (2017-2022)
Table Global Anti-Obesity Prescription Drugs Revenue Market Share by Big Type in 2019
Figure Global Orlistat Sales Growth Rate (2017-2022)
Figure Global Orlistat Price (2017-2022)
Figure Global Phentermine and Topiramate Sales Growth Rate (2017-2022)
Figure Global Phentermine and Topiramate Price (2017-2022)
Figure Global Bupropion and Naltrexone Sales Growth Rate (2017-2022)
Figure Global Bupropion and Naltrexone Price (2017-2022)
Figure Global Lorcaserin Sales Growth Rate (2017-2022)
Figure Global Lorcaserin Price (2017-2022)
Table Global Anti-Obesity Prescription Drugs Sales by Big Application (2017-2022)
Table Global Anti-Obesity Prescription Drugs Sales Market Share by Big Application (2017-2022)
Figure Global Anti-Obesity Prescription Drugs Sales Market Share by Big Application in 2019
Figure Global Pediatric Sales Growth Rate (2017-2022)
Figure Global Adult Sales Growth Rate (2017-2022)
Figure Global Anti-Obesity Prescription Drugs Sales and Growth Rate (2022-2027)
Figure Global Anti-Obesity Prescription Drugs Revenue and Growth Rate (2022-2027)
Table Global Anti-Obesity Prescription Drugs Sales Forecast by Regions (2022-2027)
Table Global Anti-Obesity Prescription Drugs Market Share Forecast by Regions (2022-2027)
Figure North America Sales Anti-Obesity Prescription Drugs Market Forecast (2022-2027)
Figure Europe Sales Anti-Obesity Prescription Drugs Market Forecast (2022-2027)
Figure China Sales Anti-Obesity Prescription Drugs Market Forecast (2022-2027)
Figure Japan Sales Anti-Obesity Prescription Drugs Market Forecast (2022-2027)
Figure Southeast Asia Sales Anti-Obesity Prescription Drugs Market Forecast (2022-2027)
Figure Other Regions Sales Anti-Obesity Prescription Drugs Market Forecast (2022-2027)
Table Global Anti-Obesity Prescription Drugs Sales Forecast by Type (2022-2027)
Table Global Anti-Obesity Prescription Drugs Market Share Forecast by Type (2022-2027)
Table Global Anti-Obesity Prescription Drugs Sales Forecast by Application (2022-2027)
Table Global Anti-Obesity Prescription Drugs Market Share Forecast by Application (2022-2027)
Table Market Opportunities in Next Few Years
Table Market Risks Analysis
Table Market Drivers
Figure Porter's Five Forces Analysis
Table Macro Analysis of Upstream Markets
Table Key Players in Upstream Markets
Table Key Players of Upstream Markets
Table Key Raw Materials
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Anti-Obesity Prescription Drugs
Table Macro Analysis of Down Markets
Table Key Players in Down Markets
Table Key Players of Downstream Markets
Figure Sales Channel
Figure North America Anti-Obesity Prescription Drugs Sales (K Units) Growth Rate Forecast (2021-2025)
Figure North America Anti-Obesity Prescription Drugs Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Europe Anti-Obesity Prescription Drugs Sales (K Units) Growth Rate Forecast (2021-2025)
Figure Europe Anti-Obesity Prescription Drugs Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Japan Anti-Obesity Prescription Drugs Production (K Units) Growth Rate Forecast (2021-2025)
Figure Japan Anti-Obesity Prescription Drugs Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure China Anti-Obesity Prescription Drugs Production (K Units) Growth Rate Forecast (2021-2025)
Figure China Anti-Obesity Prescription Drugs Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Methodology/Research Approach
Figure Market Size Estimation
Figure Author List
F Hoffmann La Roche Ltd
Orexigen Therapeutics
Novo Nordisk A/s
Arena Pharmaceuticals
Glaxosmithkline
Vivus
Global Freckle-removing Medical and Beau..
The global market for Freckle-removing Medical and Beauty Eq..
+16467917070US (Toll Free)